Showing results (2051-2060 of 2,107) with videos related to

Sort By:
Pageof 211
CNS Drugs|February 15, 2025
MDMA-Assisted Therapy for Post-Traumatic Stress Disorder: Regulatory Challenges and a Path ForwardBalwinder Singh
CNS Drugs|January 28, 2025
Raynaud Syndrome Associated with Medication for Attention-Deficit/Hyperactivity Disorder: A Systematic ReviewFrank M C Besag, Michael J Vasey, Sulagna Roy, et al.
CNS Drugs|January 17, 2025
Safety and Efficacy of Deutetrabenazine at High versus Lower Daily Dosages in the ARC-HD Study to Treat Chorea in Huntington DiseaseSamuel Frank, Claudia M Testa, Jody Goldstein, et al.
CNS Drugs|January 4, 2025
Adjunctive PCSK9 Inhibitor Evolocumab in the Prevention of Early Neurological Deterioration in Non-cardiogenic Acute Ischemic Stroke: A Multicenter, Prospective, Randomized, Open-Label, Clinical TrialWen Tian, Hua Cao, Xidan Li, et al.
CNS Drugs|January 3, 2025
The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual FactorsKelly A Sagar, Staci A Gruber
CNS Drugs|March 20, 2025
Assessing Early Efficacy After Initiation of Once-Nightly Sodium Oxybate (ON-SXB; FT218) in Participants with Narcolepsy Type 1 or 2: A Post Hoc Analysis from the Phase 3 REST-ON TrialLois Krahn, Asim Roy, John W Winkelman, et al.
CNS Drugs|March 20, 2025
Sodium Oxybate: Practical Considerations and Patient PerspectivesMaggie Lavender, Cecile Martin, Diana Anderson
CNS Drugs|March 9, 2025
Comparative Effectiveness of Different Opioid Regimens, in Daily Dose or Treatment Duration, Prescribed at Surgical Discharge: a Systematic Review and Meta-AnalysisMasoud Jamshidi, Caitlin M P Jones, Aili V Langford, et al.
CNS Drugs|March 7, 2025
The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's DiseaseYigal Paul Goldberg, Leehee Navon-Perry, Andrés Cruz-Herranz, et al.
CNS Drugs|August 22, 2024
Assessment of Bone Mineral Density Over 1 Year in a Cross-Sectional Cohort of Migraine Patients Receiving Anti-CGRP Monoclonal AntibodiesDavide Para, Chiara Camponovo, Gianna Carla Riccitelli, et al.
Pageof 211